Plain-English translation of NCT05156112 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Post Traumatic Stress Disorder research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Many veterans struggle with both substance use disorder and post-traumatic stress disorder, and untreated sleep apnea makes both conditions worse. This trial tests whether using a positive airway pressure (PAP) device—a machine that gently blows air to keep your airway open while you sleep—during a 28-day residential treatment program helps veterans recover better and improve their mental health. The study compares veterans who get the treatment right away to those who wait to receive it after the program ends.
Sleep apnea is very common in veterans with trauma and addiction but is rarely screened for or treated in addiction recovery programs. Since the medication can significantly improve sleep, mood, PTSD symptoms, and reduce the risk of suicide, the researchers want to find out if treating it early—during residential care when you're already getting help—leads to better long-term outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll spend 28 days in a residential treatment program. Half the participants will receive a PAP device to use each night during those 28 days, while the other half will wait to receive one after the program ends. You'll complete assessments during your stay and at a 3-month follow-up visit to measure how you're doing with your recovery, sleep, mood, and PTSD symptoms.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States